Some of the key features of the new facility include its efficient “smart” design, clean rooms throughout the facility, and cross-contamination prevention controls.
Photo © Shutterstock.com/Gemenacom
InvaPharm, Inc. (Ontario, CA) announced the opening of its new manufacturing facility for pharmaceutical-grade dietary supplements and cosmetic products. According to InvaPharm, the Southern California facility was built from the ground up with a focus on quality and traceability. Some key features of the new facility include its efficient “smart” design, clean rooms throughout the facility and cross-contamination prevention controls.
Of the facility’s design, Manu Patolia, founder, CEO, InvaPharm, stated: “We had the advantage of starting a facility from the ground up and [employing] the latest technological advantages. The vision for InvaPharm’s facility revolved around pharmaceutical manufacturing standards and that’s exactly what we’ve accomplished.”
Kalpesh Bodar, vice president of operations, InvaPharm, agreed, telling Nutritional Outlook that the facility’s “smart” design is based on time and motion studies “to ensure efficient manufacturing workflow from receiving to finished product packaging to shipping.” He added that the design accommodates one-directional-flow of operations. “This smart-space design…enables the company to maximize speed and efficiency, which results in faster production,” he added.
Additional measures have likewise been taken to ensure product quality, noted Jim Ayres, vice president of new business development, InvaPharm. “From pressurized isolation chambers, seamless walls and windows, metal pharmaceutical walls and ceiling, no 90-degree angles floor to ceiling, humidity, and air flow controls…it’s just unprecedented in this industry and frankly, long overdue.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.